These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. An outcome of psychodynamic psychotherapy: a case study of the change in serotonin transporter binding and the activation of the dream screen. Saarinen PI; Lehtonen J; Joensuu M; Tolmunen T; Ahola P; Vanninen R; Kuikka J; Tiihonen J Am J Psychother; 2005; 59(1):61-73. PubMed ID: 15895769 [TBL] [Abstract][Full Text] [Related]
8. Elevated hypothalamic/midbrain serotonin (monoamine) transporter availability in depressive drug-naive children and adolescents. Dahlström M; Ahonen A; Ebeling H; Torniainen P; Heikkilä J; Moilanen I Mol Psychiatry; 2000 Sep; 5(5):514-22. PubMed ID: 11032385 [TBL] [Abstract][Full Text] [Related]
9. Baseline symptom severity predicts serotonin transporter change during psychotherapy in patients with major depression. Joensuu M; Ahola P; Knekt P; Lindfors O; Saarinen P; Tolmunen T; Valkonen-Korhonen M; Vanninen R; Jääskeläinen T; Virtala E; Kuikka J; Tiihonen J; Lehtonen J Psychiatry Clin Neurosci; 2016 Jan; 70(1):34-41. PubMed ID: 26311446 [TBL] [Abstract][Full Text] [Related]
10. [[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy. Berding G; Brücke T; Odin P; Brooks DJ; Kolbe H; Gielow P; Harke H; Knoop BO; Dengler R; Knapp WH Nuklearmedizin; 2003 Feb; 42(1):31-8. PubMed ID: 12601452 [TBL] [Abstract][Full Text] [Related]
11. Lower availability of midbrain serotonin transporter between healthy subjects with and without a family history of major depressive disorder - a preliminary two-ligand SPECT study. Hsieh PC; Chen KC; Yeh TL; Lee IH; Chen PS; Yao WJ; Chiu NT; Chen CC; Liao MH; Yang YK Eur Psychiatry; 2014 Sep; 29(7):414-8. PubMed ID: 24439516 [TBL] [Abstract][Full Text] [Related]
12. Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease. Scherfler C; Seppi K; Donnemiller E; Goebel G; Brenneis C; Virgolini I; Wenning GK; Poewe W Brain; 2005 Jul; 128(Pt 7):1605-12. PubMed ID: 15817519 [TBL] [Abstract][Full Text] [Related]
13. Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder. Hesse S; Müller U; Lincke T; Barthel H; Villmann T; Angermeyer MC; Sabri O; Stengler-Wenzke K Psychiatry Res; 2005 Oct; 140(1):63-72. PubMed ID: 16213689 [TBL] [Abstract][Full Text] [Related]
14. Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I-beta-CIT SPECT. Kim SE; Choi JY; Choe YS; Choi Y; Lee WY J Nucl Med; 2003 Jun; 44(6):870-6. PubMed ID: 12791812 [TBL] [Abstract][Full Text] [Related]
15. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram. de Win MM; Habraken JB; Reneman L; van den Brink W; den Heeten GJ; Booij J Neuropsychopharmacology; 2005 May; 30(5):996-1005. PubMed ID: 15770240 [TBL] [Abstract][Full Text] [Related]
16. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Staley JK; Krishnan-Sarin S; Zoghbi S; Tamagnan G; Fujita M; Seibyl JP; Maciejewski PK; O'Malley S; Innis RB Synapse; 2001 Sep; 41(4):275-84. PubMed ID: 11494398 [TBL] [Abstract][Full Text] [Related]
17. Serotonin transporter binding with [123I]beta-CIT SPECT in major depressive disorder versus controls: effect of season and gender. Ruhé HG; Booij J; Reitsma JB; Schene AH Eur J Nucl Med Mol Imaging; 2009 May; 36(5):841-9. PubMed ID: 19183998 [TBL] [Abstract][Full Text] [Related]
18. Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT. Laruelle M; Abi-Dargham A; van Dyck C; Gil R; D'Souza DC; Krystal J; Seibyl J; Baldwin R; Innis R Biol Psychiatry; 2000 Mar; 47(5):371-9. PubMed ID: 10704949 [TBL] [Abstract][Full Text] [Related]